The company said net income attributable to Bunge for Q2 (3 months) was $70 million, down from $622 million a year earlier. Diluted earnings per share were $0.48, compared with $4.09 a year earlier.

1. 01

   The company said net income attributable to Bunge for Q2 (3 months) was $70 million, down from $622 million a year earlier. Diluted earnings per share were $0.48, compared with $4.09 a year earlier.

2. 02

   The company reported that Agribusiness Segment EBIT for Q2 (3 months) was $138 million, down from $785 million a year earlier, and that Gross Profit was $289 million, compared with $997 million a year earlier.

3. 03

   Bunge said cash used in operating activities was $480 million for the 6 months ended June 30, 2024, compared with cash provided of $472 million in the same period last year. The company cited lower net income and net changes in working capital as factors. Adjusted funds from operations was $895 million.

4. 04

   The company said on June 19, 2024 that it entered into a definitive share purchase agreement to sell its 50% ownership share in BP Bunge Bioenergia. The company said it expects the transaction to close in late 2024, subject to customary closing conditions.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.